previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | next
| CSGID ID | Priority | Locus Tag | NCBI GI | Gene Name |
Common Name | Sequence Length |
Comment | Project | Homolog PDB ID |
Homolog Sequence Identity |
Target Organism | TIGR Main Role | TIGR Subrole | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IDP00694 | 1 | SACOL2151 | 57286365 | glmM | phosphoglucosamine mutase GlmM | 451 | Drug Target Function | March 2008 | 1WQA | 35% | Staphylococcus aureus | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00778 | 1 | SACOL0668 | 57284264 | hydrolase, alpha/beta hydrolase fold fam... | 266 | Drug Target Function | March 2008 | 1VA4 | 27.4% | Staphylococcus aureus | Unknown function | Enzymes of unknown specificity | ||||||||||||||||||
| IDP00616 | 1 | SACOL1586 | 57286108 | hypothetical protein SACOL1586 | 94 | Drug Target Function | March 2008 | Staphylococcus aureus | 0 | 0 | ||||||||||||||||||||
| IDP00982 | 1 | STM2062 | 16765392 | dacD | D-alanyl-D-alanine carboxypeptidase | 390 | Drug Target Function | March 2008 | 1NZO | 45.1% | Salmonella typhimurium | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00538 | 1 | YPO0070 | 16120421 | cysE | serine acetyltransferase | 273 | Drug Target Function | March 2008 | 1T3D | 86.1% | Yersinia pestis | Amino acid biosynthesis | Serine family | |||||||||||||||||
| IDP00898 | 1 | STM2114 | 16765444 | wcaB | putative colanic acid biosynthesis acety... | 162 | Drug Target Function | March 2008 | 1T3D | 29.6% | Salmonella typhimurium | Amino acid biosynthesis | Serine family | |||||||||||||||||
| IDP00670 | 1 | SACOL1212 | 57285955 | pyrB | aspartate carbamoyltransferase catalytic... | 293 | Drug Target Function | March 2008 | 2AT2 | 56% | Staphylococcus aureus | Purines, pyrimidines, nucleosides, and nucleotides | Pyrimidine ribonucleotide biosynthesis | |||||||||||||||||
| IDP00590 | 1 | YPO1078 | 16121379 | mltD | predicted membrane-bound lytic murein tr... | 475 | Drug Target Function | March 2008 | 1E0G | 7.8% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00871 | 1 | STM1444 | 161353603 | slyA | transcriptional regulator SlyA | 144 | Drug Target Function | March 2008 | 3DEU | 97.9% | Salmonella typhimurium | Cellular processes | Toxin production and resistance | |||||||||||||||||
| IDP00308 | 1 | CBU_0288 | 29653640 | coaD | phosphopantetheine adenylyltransferase | 159 | Drug Target Function | March 2008 | 1OD6 | 47.2% | Coxiella burnetii | Biosynthesis of cofactors, prosthetic groups, and carriers | Pantothenate and coenzyme A | |||||||||||||||||
| IDP00583 | 1 | YPO2752 | 16122956 | mepA | penicillin-insensitive murein endopeptid... | 275 | Drug Target Function | March 2008 | 1TZP | 67.6% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00548 | 1 | YPO0549 | 16120877 | ftsI | penicillin-binding protein 3 | 587 | Drug Target Function | March 2008 | 3EQU | 36.6% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00320 | 1 | CBU_0550 | 29653890 | pbpA | penicillin-binding protein 2 | 612 | Drug Target Function | March 2008 | 1MWR | 25.3% | Coxiella burnetii | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00319 | 1 | CBU_2070 | 29655348 | chorismate mutase, putative | 136 | Drug Target Function | March 2008 | Coxiella burnetii | Amino acid biosynthesis | Aromatic amino acid family | ||||||||||||||||||||
| IDP00307 | 1 | CBU_0142 | 29653500 | lpxC | UDP-3-0-acyl N-acetylglucosamine deacety... | 303 | Drug Target Function | March 2008 | 2VES | 65.7% | Coxiella burnetii | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | |||||||||||||||||
| IDP00311 | 1 | CBU_0494 | 29653836 | fabD | malonyl CoA-acyl carrier protein transac... | 313 | Drug Target Function | March 2008 | 1MLA | 54% | Coxiella burnetii | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP00312 | 1 | CBU_0497 | 29653839 | fabF | 3-oxoacyl-acyl carrier protein synthase ... | 414 | Drug Target Function | March 2008 | 1B3N | 60.1% | Coxiella burnetii | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP00304 | 1 | CBU_0038 | 29653401 | 3-oxoacyl-(acyl-carrier-protein) synthas... | 327 | Drug Target Function | March 2008 | 1UB7 | 29.4% | Coxiella burnetii | Fatty acid and phospholipid metabolism | Biosynthesis | ||||||||||||||||||
| IDP00434 | 1 | YPO0796 | 16121108 | lysA | diaminopimelate decarboxylase | 420 | Drug Target Function | March 2008 | 1KNW | 76.9% | Yersinia pestis | Amino acid biosynthesis | Aspartate family | |||||||||||||||||
| IDP00327 | 1 | Cj1634c | 15792939 | aroC | chorismate synthase | 362 | Drug Target Function | March 2008 | 1SQ1 | 100% | Campylobacter jejuni | Hypothetical proteins | Conserved | |||||||||||||||||
| IDP01376 | 1 | VC0400 | 15640427 | MSHA biogenesis protein MshJ | 216 | Drug Target Function | March 2008 | Vibrio cholerae | Cellular processes | Pathogenesis | ||||||||||||||||||||
| IDP01135 | 1 | BA_3911 | 30258425 | renal dipeptidase family protein | 307 | Drug Target Function | March 2008 | 1ITQ | 23.8% | Bacillus anthracis | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP00314 | 1 | CBU_0751 | 29654085 | murA | UDP-N-acetylglucosamine 1-carboxyvinyltr... | 434 | Drug Target Function | March 2008 | 1EJC | 56.9% | Coxiella burnetii | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00418 | 1 | YPO0910 | 16121215 | pepP | proline aminopeptidase P II | 437 | Drug Target Function | March 2008 | 1A16 | 81.2% | Yersinia pestis | Protein fate | Degradation of proteins, peptides, and glycopeptides | |||||||||||||||||
| IDP00316 | 1 | CBU_1152 | 29654458 | trpE | anthranilate synthase component I | 463 | Drug Target Function | March 2008 | 1QDL | 34.3% | Coxiella burnetii | Amino acid biosynthesis | Aromatic amino acid family | |||||||||||||||||
| IDP00498 | 1 | YPO0166 | 16120509 | putative glycosyl hydrolase | 437 | Drug Target Function | March 2008 | 1S6Y | 52.6% | Yersinia pestis | Energy metabolism | Biosynthesis and degradation of polysaccharides | ||||||||||||||||||
| IDP00305 | 1 | CBU_0118 | 29653476 | pbpB | penicillin-binding protein 3 | 548 | Drug Target Function | March 2008 | 3EQU | 39.2% | Coxiella burnetii | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00318 | 1 | CBU_1947 | 29655231 | glmU | UDP-N-acetylglucosamine pyrophosphorylas... | 455 | Drug Target Function | March 2008 | 1HV9 | 51.4% | Coxiella burnetii | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | |||||||||||||||||
| IDP00433 | 1 | YPO1545 | 16121818 | hisH | imidazole glycerol phosphate synthase su... | 196 | Drug Target Function | March 2008 | 1OX4 | 38.3% | Yersinia pestis | Amino acid biosynthesis | Histidine family | |||||||||||||||||
| IDP00317 | 1 | CBU_1887 | 29655172 | ponA | penicillin-binding protein 1A | 793 | Drug Target Function | March 2008 | 2OLU | 23.2% | Coxiella burnetii | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00310 | 1 | CBU_0493 | 29653835 | fabH | 3-oxoacyl-(acyl-carrier-protein) synthas... | 319 | Drug Target Function | March 2008 | 1HN9 | 54.5% | Coxiella burnetii | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP00313 | 1 | CBU_0647 | 29653985 | ribA | riboflavin biosynthesis protein RibA | 406 | Drug Target Function | March 2008 | 2BZ0 | 27.1% | Coxiella burnetii | Biosynthesis of cofactors, prosthetic groups, and carriers | Riboflavin, FMN, and FAD | |||||||||||||||||
| IDP00315 | 1 | CBU_0874 | 29654200 | aroC | chorismate synthase | 352 | Drug Target Function | March 2008 | 1R52 | 46.6% | Coxiella burnetii | Amino acid biosynthesis | Aromatic amino acid family | |||||||||||||||||
| IDP00303 | 1 | CBU_0035 | 29653398 | beta-ketoacyl synthase | 424 | Drug Target Function | March 2008 | 3E60 | 37.3% | Coxiella burnetii | Fatty acid and phospholipid metabolism | Biosynthesis | ||||||||||||||||||
| IDP00417 | 1 | YPO2604 | 16122817 | pbpA | penicillin-binding protein 2 | 631 | Drug Target Function | March 2008 | 1MWR | 23.6% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00302 | 1 | CBU_1155 | 29654460 | trpBF | N-(5'phosphoribosyl)anthranilate isomera... | 600 | Drug Target Function | March 2008 | 1V8Z | 38% | Coxiella burnetii | Amino acid biosynthesis | Aromatic amino acid family | |||||||||||||||||
| IDP01134 | 1 | BA_2001 | 30256654 | intracellular serine protease | 316 | Drug Target Function | March 2008 | 1AK9 | 38% | Bacillus anthracis | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP01193 | 1 | BA_1185 | 30254899 | fabF | 3-oxoacyl-(acyl-carrier-protein) synthas... | 412 | Drug Target Function | March 2008 | 2GQD | 64.8% | Bacillus anthracis | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP01493 | 1 | VCA0751 | 161582040 | 3-oxoacyl-(acyl carrier protein) synthas... | 362 | Drug Target Function | March 2008 | 2EBD | 40.9% | Vibrio cholerae | Fatty acid and phospholipid metabolism | Biosynthesis | ||||||||||||||||||
| IDP01248 | 1 | BA_3554 | 30258085 | penicillin-binding protein, putative | 377 | Drug Target Function | March 2008 | 2QMI | 22.3% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01373 | 1 | VC0335 | 15640362 | NlpD-related protein | 382 | Drug Target Function | March 2008 | Vibrio cholerae | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||||
| IDP01413 | 1 | VC1174 | 15641187 | anthranilate synthase component I | 523 | Drug Target Function | March 2008 | 1I1Q | 59.3% | Vibrio cholerae | Amino acid biosynthesis | Aromatic amino acid family | ||||||||||||||||||
| IDP00556 | 1 | YPO2686 | 16122891 | pgm | phosphoglucomutase | 547 | Drug Target Function | March 2008 | 2FUV | 82.4% | Yersinia pestis | Energy metabolism | Sugars | |||||||||||||||||
| IDP00309 | 1 | CBU_0298 | 29653649 | murI | glutamate racemase | 280 | Drug Target Function | March 2008 | 2GZM | 38.2% | Coxiella burnetii | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00427 | 1 | YPO4119 | 16124227 | glmU | bifunctional N-acetylglucosamine-1-phosp... | 456 | Drug Target Function | March 2008 | 1HV9 | 82.2% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | |||||||||||||||||
| IDP00662 | 1 | SACOL0945 | 57285819 | cytosol aminopeptidase | 491 | Drug Target Function | March 2008 | 1GYT | 31.4% | Staphylococcus aureus | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP00595 | 1 | YPO3760 | 16123897 | murB | UDP-N-acetylenolpyruvoylglucosamine redu... | 345 | Drug Target Function | March 2008 | 1MBB | 60.9% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01244 | 1 | BA_2504 | 30257132 | penicillin-binding protein | 588 | Drug Target Function | March 2008 | 1MWR | 23.6% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01381 | 1 | VC0529 | 15640551 | ispF | 2-C-methyl-D-erythritol 2,4-cyclodiphosp... | 158 | Drug Target Function | March 2008 | 1GX1 | 74.7% | Vibrio cholerae | Biosynthesis of cofactors, prosthetic groups, and carriers | Other | |||||||||||||||||
| IDP01172 | 1 | BA_1206 | 30255158 | pepF-1 | oligoendopeptidase F | 608 | Drug Target Function | March 2008 | 2QR4 | 51% | Bacillus anthracis | Protein fate | Degradation of proteins, peptides, and glycopeptides | |||||||||||||||||
| IDP01407 | 1 | VC0947 | 15640963 | D-alanyl-D-alanine carboxypeptidase | 391 | Drug Target Function | March 2008 | 1NZO | 52.2% | Vibrio cholerae | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01397 | 1 | VC0755 | 161582019 | aminopeptidase B | 429 | Drug Target Function | March 2008 | 1GYT | 29.8% | Vibrio cholerae | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP01051 | 1 | STM3219 | 16766518 | fadH | 2,4-dieonyl-CoA reductase | 672 | Drug Target Function | March 2008 | 1PS9 | 85.6% | Salmonella typhimurium | Fatty acid and phospholipid metabolism | Degradation | |||||||||||||||||
| IDP01361 | 1 | VC0157 | 15640187 | alkaline serine protease | 535 | Drug Target Function | March 2008 | 1S2N | 35.7% | Vibrio cholerae | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP01221 | 1 | BA_3990 | 30258499 | fabD | malonyl CoA-acyl carrier protein transac... | 314 | Drug Target Function | March 2008 | 1MLA | 44.9% | Bacillus anthracis | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP00528 | 1 | YPO0481 | 16120811 | carA | carbamoyl phosphate synthase small subun... | 391 | Drug Target Function | March 2008 | 1BXR | 84.4% | Yersinia pestis | Purines, pyrimidines, nucleosides, and nucleotides | Pyrimidine ribonucleotide biosynthesis | |||||||||||||||||
| IDP01437 | 1 | VC1983 | 15641985 | peptidase, putative | 615 | Drug Target Function | March 2008 | Vibrio cholerae | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||||
| IDP01428 | 1 | VC1709 | 15641713 | zinc protease, insulinase family | 922 | Drug Target Function | March 2008 | 3CWW | 19% | Vibrio cholerae | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP01477 | 1 | VC2762 | 15642755 | glmU | bifunctional N-acetylglucosamine-1-phosp... | 453 | Drug Target Function | March 2008 | 1HV9 | 67.5% | Vibrio cholerae | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00306 | 1 | CBU_0137 | 29653495 | murB | UDP-N-acetylenolpyruvoylglucosamine redu... | 316 | Drug Target Function | March 2008 | 1HSK | 34.5% | Coxiella burnetii | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP00596 | 1 | YPO0555 | 16120883 | murG | N-acetylglucosaminyl transferase | 356 | Drug Target Function | March 2008 | 1F0K | 78.4% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01438 | 1 | VC1993 | 15641995 | 2,4-dienoyl-CoA reductase | 666 | Drug Target Function | March 2008 | 1PS9 | 57.1% | Vibrio cholerae | Fatty acid and phospholipid metabolism | Degradation | ||||||||||||||||||
| IDP00962 | 1 | STM1427 | 16764775 | cfa | cyclopropane fatty acyl phospholipid syn... | 382 | Drug Target Function | March 2008 | 1KP9 | 26.7% | Salmonella typhimurium | Fatty acid and phospholipid metabolism | Biosynthesis | |||||||||||||||||
| IDP00464 | 1 | YPO2522 | 16122741 | hypothetical protein YPO2522 | 319 | Drug Target Function | March 2008 | 1V8G | 24.5% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP00321 | 1 | Cj1105 | 15792430 | smpB | SsrA-binding protein | 150 | Drug Target Function | March 2008 | 1P6V | 47.3% | Campylobacter jejuni | Purines, pyrimidines, nucleosides, and nucleotides | Pyrimidine ribonucleotide biosynthesis | |||||||||||||||||
| IDP01239 | 1 | BA_5670 | 30260118 | glycosyl transferase, group 1 family pro... | 366 | Drug Target Function | March 2008 | 2JJM | 26.2% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP01249 | 1 | BA_4055 | 30258562 | penicillin-binding protein | 716 | Drug Target Function | March 2008 | 1QME | 30.7% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP01234 | 0 | BA_5509 | 30259969 | UDP-N-acetylglucosamine 2-epimerase | 371 | Drug Target Function | March 2008 | 3BEO | 100% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of surface polysaccharides and lipopolysaccharides | ||||||||||||||||||
| IDP01515 | 1 | VCA0836 | 15601591 | hexapeptide-repeat containing-acetyltran... | 192 | Drug Target Function | March 2008 | 3ECT | 100% | Vibrio cholerae | Central intermediary metabolism | Other | ||||||||||||||||||
| IDP01372 | 1 | VC0318 | 15640345 | murB | UDP-N-acetylenolpyruvoylglucosamine redu... | 357 | Drug Target Function | March 2008 | 1MBB | 46.8% | Vibrio cholerae | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01386 | 1 | VC0565 | 15640587 | protease DegS | 352 | Drug Target Function | March 2008 | 1SOT | 47.7% | Vibrio cholerae | Protein fate | Degradation of proteins, peptides, and glycopeptides | ||||||||||||||||||
| IDP01247 | 1 | BA_3214 | 30257780 | penicillin-binding protein, putative | 691 | Drug Target Function | March 2008 | 2QMI | 14.2% | Bacillus anthracis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | ||||||||||||||||||
| IDP00591 | 1 | YPO0145 | 161486893 | mrcA | penicillin-binding protein | 859 | Drug Target Function | March 2008 | 2JCH | 21% | Yersinia pestis | Cell envelope | Biosynthesis and degradation of murein sacculus and peptidoglycan | |||||||||||||||||
| IDP01332 | 1 | VC0639 | 15640659 | |||||||||||||||||||||||||||